SCHEMBL8256995

SCHEMBL8256995

CCCc1cncc(-c2csc([C@@]3(C)NC(=N)N(C)C(=O)C3N3CCOCC3)c2)c1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8436769 0.88 BACE1 (0.35) BACE1
SCHEMBL15291973 0.85 BACE1 (0.49) BACE1
SCHEMBL4557575 0.70 BACE1 (0.38) BACE1
SCHEMBL4558947 0.70 BACE1 (0.35) BACE1
SCHEMBL13558883 0.70 CYP11B1 (0.36) BACE1
SCHEMBL4557576 0.69 BACE1 (0.37) BACE1
SCHEMBL4559913 0.69 BACE1 (0.37) BACE1
SCHEMBL14105837 0.69 BACE1 (0.33) BACE1
SCHEMBL4559951 0.68 BACE1 (0.36) BACE1
SCHEMBL4558945 0.68 BACE1 (0.36) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287692-A1 ASPARTYL PROTEASE INHIBITORS MERCK SHARP & DOHME LLC 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287692-A1 ASPARTYL PROTEASE INHIBITORS CHRM1, CHRM2, BACE1 BACE1 3/4885TSHR 654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.